Ascentage Pharma Group International (HKG:6855)
Hong Kong
· Delayed Price · Currency is HKD 50.65
+5.15 (11.32%)
Apr 24, 2025, 4:08 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 583 employees as of December 31, 2023. The number of employees increased by 3 or 0.52% compared to the previous year.
Employees
583
Change (1Y)
3
Growth (1Y)
0.52%
Revenue / Employee
1.84M HKD
Profits / Employee
-760.94K HKD
Market Cap
17.64B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | 433 | 23 | 5.61% |
| Dec 31, 2019 | 410 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeiGene | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| WuXi Biologics | 12,575 |
| Innovent Biologics | 5,659 |
| Akeso | 3,035 |
| Alibaba Health Information Technology | 1,435 |
| CSPC Pharmaceutical Group | 21,400 |
Ascentage Pharma Group International News
- 27 days ago - Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan - Benzinga
- 4 weeks ago - Earnings Scheduled For March 27, 2025 - Benzinga
- 4 weeks ago - Ascentage Pharma Group International (AAPG) Showcases Innovative Cancer Therapies at AACR 2025 - GuruFocus
- 3 months ago - Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO - Reuters
- 3 months ago - Ascentage Pharma Announces Pricing of U.S. Initial Public Offering - GlobeNewsWire
- 3 months ago - Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO - Reuters
- 4 months ago - Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months - PRNewsWire